Prognostic factors for patients operated on for a IIIAN2 non-small cell lung cancer: A retrospective study

被引：0
|
作者：
Bakhti, Ahmed [1 ]
Abdennadher, Mahdi [1 ]
Zribi, Hazem [1 ]
Abdlekbir, Amina [1 ]
Ouerghi, Sonia [2 ]
Mlika, Mouna [3 ]
Zairi, Sarra [1 ]
Marghli, Adel [1 ]
Zairi, Sarra [1 ]
机构：
[1] Abderrahmen Mami Hosp, Thorac Surg Dept, Tunis, Tunisia
[2] Abderrahmen Mami Hosp, Anesthesia Dept, Tunis, Tunisia
[3] Abderrahmen Mami Hosp, Histopathol Dept, Tunis, Tunisia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA5148
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Satoh, Hiroaki
    Iguchi, Kesato
    Nakamura, Ryota
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (04): : 314 - 314
  • [32] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Moskalenko, Yuliia
    Smorodska, Olga
    Deineka, Volodymyr
    Kravets, Oleksandr
    Moskalenko, Roman
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (03): : 239 - 246
  • [33] Prognostic factors of 112 elderly patients with advanced non-small cell lung cancer
    Ran, Fanglan
    Liu, Qjn
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (06) : 1674 - 1679
  • [34] Survival outcomes and prognostic factors in elderly patients with non-small cell lung cancer
    Park, S.
    Park, J. H.
    Kim, J. S.
    Choi, I. S.
    Kim, K. H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S192 - S193
  • [35] Prognostic Factors for Resected Non-Small Cell Lung Cancer in Patients with Type 2 Diabetes Mellitus
    Yu, W. S.
    Lee, J. G.
    Suh, J. W.
    Park, S. Y.
    Lee, C. Y.
    Kim, D. J.
    Chung, K. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2350 - S2350
  • [36] Prognostic factors for resected non-small cell lung cancer in patients with type 2 diabetes mellitus
    Yu, Woo Sik
    Lee, Chang Young
    Park, Seong Yong
    Suh, Jee Won
    Narm, Kyoung Shik
    Kim, Dae Joon
    Chung, Kyung Young
    Lee, Jin Gu
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (05) : 985 - 993
  • [37] Prognostic Factors in Patients with Resected Pathological N2 Non-Small Cell Lung Cancer
    Goto, T.
    Nakamura, M.
    Shimizu, Y.
    Sato, S.
    Koike, T.
    Tsuchida, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S879 - S879
  • [38] Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients
    Zhu Chihong
    Ling Yutian
    Wan Danying
    Jiang Ruibin
    Sheng Huaying
    Gu Linhui
    Feng Jianguo
    ONCOTARGET, 2017, 8 (28) : 45577 - 45584
  • [39] Prognostic factors for survival of stage IB upper lobe non-small cell lung cancer patients: A retrospective study in Shanghai, China
    Wang, Wen-li
    Yang Shen-tu
    Wang, Zhi-qiang
    CHINESE JOURNAL OF CANCER RESEARCH, 2011, 23 (04) : 265 - 270
  • [40] Gemcitabine and cisplatin as induction chemotherapy in stage IIIAN2/IIIB non-small cell lung cancer (NSCLC). A mono-institutional phase II study with a 21 days schedule
    Migliorino, MR
    De Marinis, F
    Nelli, F
    Faccialo, F
    Ammaturo, MV
    Ramponi, S
    Ariganello, O
    Di Molfetta, M
    Diana, F
    Belli, R
    Martelli, M
    ANNALS OF ONCOLOGY, 2000, 11 : 8 - 8
12345